Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies

Yasushi Fuchimoto, Nobuyuki Morikawa, Tatsuo Kuroda, Seiichi Hirobe, Shouichiro Kamagata, Masaaki Kumagai, Kentaro Matsuoka, Yasuhide Morikawa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Fingerprint Dive into the research topics of 'Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies'. Together they form a unique fingerprint.